✦ LIBER ✦

Is postoperative adjuvant chemoradiotherapy necessary for high-risk oropharyngeal squamous cell carcinoma?

✍ Scribed by Yokota, Tomoya; Onitsuka, Tetsuro; Kusafuka, Kimihide; Ogawa, Hirofumi; Onozawa, Yusuke; Nakagawa, Masahiro; Iida, Yoshiyuki; Kamijo, Tomoyuki; Nishimura, Tetsuo; Nakajima, Takashi; Boku, Narikazu; Yasui, Hirofumi

Book ID: 121549074
Publisher: Springer
Year: 2013
Tongue: English
Weight: 208 KB
Volume: 19
Category: Article
ISSN: 1341-9625
DOI: 10.1007/s10147-013-0532-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Feasibility of postoperative concurrent

Feasibility of postoperative concurrent chemoradiotherapy in Japanese patients with oral squamous cell carcinoma showing high-risk factors for recurrence

✍ Yamada, Shin-ichi; Yanamoto, Souichi; Takahashi, Hidenori; Naruse, Tomofumi; Shi 📂 Article 📅 2015 🏛 Elsevier 🌐 English ⚖ 480 KB

Postoperative Chemoradiotherapy and Cetu

Postoperative Chemoradiotherapy and Cetuximab for High-Risk Squamous Cell Carcinoma of the Head and Neck: Radiation Therapy Oncology Group RTOG-0234

✍ Harari, P. M.; Harris, J.; Kies, M. S.; Myers, J. N.; Jordan, R. C.; Gillison, M 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 297 KB

PD.189 Outcomes for adjuvant radiotherap

PD.189 Outcomes for adjuvant radiotherapy in oral and oropharyngeal squamous cell carcinoma stratified by risk of disease progression

✍ T.K. Blackburn; J.S. Brown; S.N. Rogers; D. Lowe; D.N. Sutton; E.D. Vaughan; D. 📂 Article 📅 2005 🏛 Elsevier Science ⚖ 130 KB

Postoperative Concurrent Radiotherapy an

Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck

✍ Cooper, Jay S.; Pajak, Thomas F.; Forastiere, Arlene A.; Jacobs, John; Campbell, 📂 Article 📅 2004 🏛 Massachusetts Medical Society 🌐 English ⚖ 192 KB

Pretreatment carcinoembryonic antigen le

Pretreatment carcinoembryonic antigen level is a risk factor for para-aortic lymph node recurrence in addition to squamous cell carcinoma antigen following definitive concurrent chemoradiotherapy for squamous cell carcinoma of the uterine cervix

✍ Eng-Yen Huang; Yu-Jie Huang; Chan-Chao Chanchien; Hao Lin; Chong-Jong Wang; Li-M 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 228 KB

Sorafenib or sunitinib as postoperative

Sorafenib or sunitinib as postoperative adjuvant therapy for Chinese patients with locally advanced clear cell renal cell carcinoma at high risk for disease recurrence

✍ Zhao, Juping; Zhu, Yu; Zhang, Chongyu; Wang, Xiaojing; He, Hongchao; Wang, Haofe 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 160 KB